Doximity Operating Income 2020-2025 | DOCS
Doximity annual/quarterly operating income history and growth rate from 2020 to 2025. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
- Doximity operating income for the quarter ending March 31, 2025 was $0.049B, a 16.31% increase year-over-year.
- Doximity operating income for the twelve months ending March 31, 2025 was $0.228B, a 39.01% increase year-over-year.
- Doximity annual operating income for 2025 was $0.228B, a 39.01% increase from 2024.
- Doximity annual operating income for 2024 was $0.164B, a 30.99% increase from 2023.
- Doximity annual operating income for 2023 was $0.125B, a 10.19% increase from 2022.
| Doximity Annual Operating Income (Millions of US $) |
|
|---|---|
| 2025 | $228 |
| 2024 | $164 |
| 2023 | $125 |
| 2022 | $114 |
| 2021 | $53 |
| 2020 | $22 |
| 2019 | $7 |
| Doximity Quarterly Operating Income (Millions of US $) |
|
|---|---|
| 2025-03-31 | $49 |
| 2024-12-31 | $80 |
| 2024-09-30 | $53 |
| 2024-06-30 | $46 |
| 2024-03-31 | $42 |
| 2023-12-31 | $59 |
| 2023-09-30 | $34 |
| 2023-06-30 | $30 |
| 2023-03-31 | $33 |
| 2022-12-31 | $38 |
| 2022-09-30 | $32 |
| 2022-06-30 | $22 |
| 2022-03-31 | $28 |
| 2021-12-31 | $36 |
| 2021-09-30 | $25 |
| 2021-06-30 | $25 |
| 2021-03-31 | $11 |
| 2020-12-31 | $18 |
| 2020-09-30 | $10 |
| 2020-06-30 | $2 |
| 2020-03-31 | |
| 2019-03-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $10.881B | $0.570B |
| Doximity Inc. provides digital platform for medical professionals. The company's network members include physicians across all specialties and practice areas. It provide its verified clinical membership with digital tools built for medicine, enabling them to collaborate with colleagues, stay up to date with the latest medical news and research, manage their careers and conduct virtual patient visits. Doximity Inc. is based in SAN FRANCISCO. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $45.994B | 58.52 |
| Hims & Hers Health (HIMS) | United States | $12.427B | 102.82 |
| Tempus AI (TEM) | United States | $9.996B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $5.151B | 0.00 |
| Hinge Health (HNGE) | United States | $3.762B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $2.600B | 38.22 |
| Privia Health (PRVA) | United States | $2.371B | 162.08 |
| 10x Genomics (TXG) | United States | $1.639B | 0.00 |
| Phreesia (PHR) | United States | $1.613B | 0.00 |
| Enovis (ENOV) | United States | $1.511B | 8.43 |
| Clover Health Investments (CLOV) | United States | $1.450B | 0.00 |
| Schrodinger (SDGR) | United States | $1.441B | 0.00 |
| Omnicell (OMCL) | United States | $1.429B | 26.99 |
| Azenta (AZTA) | United States | $1.231B | 53.80 |
| Evolent Health (EVH) | United States | $1.115B | 95.00 |
| Claritev (CTEV) | United States | $0.650B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.636B | 0.00 |
| Veradigm (MDRX) | United States | $0.514B | 0.00 |
| Standard BioTools (LAB) | United States | $0.494B | 0.00 |
| Talkspace (TALK) | United States | $0.380B | 113.50 |
| Zepp Health (ZEPP) | Netherlands | $0.349B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.336B | 0.00 |
| Carlsmed (CARL) | $0.325B | 0.00 | |
| TruBridge (TBRG) | United States | $0.314B | 696.33 |
| Health Catalyst (HCAT) | United States | $0.266B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.254B | 0.00 |
| Outset Medical (OM) | United States | $0.250B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.228B | 0.00 |
| CapsoVision (CV) | United States | $0.192B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.151B | 0.00 |
| American Well (AMWL) | United States | $0.132B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.118B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.113B | 0.00 |
| CareCloud (CCLD) | United States | $0.101B | 4.58 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.084B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.075B | 0.00 |
| Pulmonx (LUNG) | United States | $0.067B | 0.00 |
| 111 (YI) | China | $0.059B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.050B | 0.00 |
| HeartBeam (BEAT) | United States | $0.034B | 0.00 |
| Zhongchao (ZCMD) | China | $0.024B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.023B | 0.00 |
| Precipio (PRPO) | United States | $0.022B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.013B | 0.00 |
| HeartSciences (HSCS) | United States | $0.008B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.008B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.008B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.007B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.007B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.005B | 0.00 |
| Movano (MOVE) | United States | $0.004B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
| PROFUSA (PFSA) | United States | $0.003B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |